Vir Biotechnology, Inc. (Vir Bio) completed a public offering of its common stock. The company sold an aggregate of 20,294,117 shares of common stock at a price of $8.50 per share. This total includes the full exercise of the underwriters' option to purchase an additional 2,647,058 shares. Vir Bio received approximately $172.5 million in gross proceeds from the offering, before deducting underwriting discounts, commissions, and estimated expenses.